Letter by Gazmuri and Karmazyn Regarding Article, "Activation and Inhibition of SodiumHydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure"

被引：1
|
作者：
Gazmuri, Raul J. [1 ,2 ,3 ]
Karmazyn, Morris
机构：
[1] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60064 USA
[2] Rosalind Franklin Univ Med & Sci, Dept Clin Sci, N Chicago, IL 60064 USA
[3] Captain James A Lovell Fed Hlth Care Ctr, Sect Crit Care Med, N Chicago, IL 60064 USA
来源：
CIRCULATION | 2018年 / 137卷 / 18期
关键词：
D O I：
10.1161/CIRCULATIONAHA.117.032824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1979 / 1980
页数：2
相关论文
共 50 条
  • [1] Response by Packer to Letter Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchange Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure"
    Packer, Milton
    CIRCULATION, 2018, 137 (18) : 1981 - 1982
  • [2] Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure
    Packer, Milton
    CIRCULATION, 2017, 136 (16) : 1548 - 1559
  • [3] Letter to the Editor regarding the article “The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions”
    Michael Dandel
    Gerd Wallukat
    Roland Hetzer
    Heart Failure Reviews, 2018, 23 : 817 - 818
  • [4] Letter to the Editor regarding the article "The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions"
    Dandel, Michael
    Wallukat, Gerd
    Hetzer, Roland
    HEART FAILURE REVIEWS, 2018, 23 (05) : 817 - 818
  • [5] Letter to the Editor regarding the article "The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions" Response
    Ofstad, Anne Pernille
    Atar, Dan
    Gullestad, Lars
    Langslet, Gisle
    Johansen, Odd Erik
    HEART FAILURE REVIEWS, 2018, 23 (05) : 819 - 819
  • [6] Letter by Elghazaly et al Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus"
    Elghazaly, Hussein
    Hajiev, Saur
    Singh, Parminder
    CIRCULATION, 2019, 140 (18) : E738 - E739
  • [7] Diabetes Mellitus Type 2 and Heart Failure - from Pathophysiology to Treatment
    Schneider, C. A.
    Stratmann, B.
    DIABETES STOFFWECHSEL UND HERZ, 2020, 29 (04): : 225 - 233
  • [8] Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
    Nakamura, Kazufumi
    Miyoshi, Toru
    Yoshida, Masashi
    Akagi, Satoshi
    Saito, Yukihiro
    Ejiri, Kentaro
    Matsuo, Naoaki
    Ichikawa, Keishi
    Iwasaki, Keiichiro
    Naito, Takanori
    Namba, Yusuke
    Yoshida, Masatoki
    Sugiyama, Hiroki
    Ito, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [9] Response by Kato et al to Letter Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus"
    Kato, Eri T.
    Sabatine, Marc S.
    Wiviott, Stephen D.
    CIRCULATION, 2019, 140 (18) : E740 - E741
  • [10] Letter regarding the paper "Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus"
    Cordero, Alberto
    Olmo, Rosa Fernandez
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (05) : 546 - 546
12345